L. Gerald Hogue's Insider Trades & SAST Disclosures
L. Gerald Hogue's most recent trade in POINT Biopharma Global Inc was a trade of 44,749 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on Dec. 26, 2023.
Add Superstar Alert
Share
Note
This is a custom search result for pattern L. Gerald Hogue.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| POINT Biopharma Global Inc | L. Gerald Hogue | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 26 Dec 2023 | 44,749 | 0 | - | - | Stock Option (Right to Buy) | |
| POINT Biopharma Global Inc | L. Gerald Hogue | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 26 Dec 2023 | 25,614 | 0 | - | - | Stock Option (Right to Buy) | |
| POINT Biopharma Global Inc | Gerald Hogue L. | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 26 Dec 2023 | 25,000 | 0 | - | - | Stock Option (Right to Buy) | |
| POINT Biopharma Global Inc | Hogue Gerald L. | Director | 26 Dec 2023 | 21,596 | 0 | - | - | Common Stock | ||
| POINT Biopharma Global Inc | Gerald L. Hogue | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 26 Dec 2023 | 17,936 | 0 | - | - | Stock Option (Right to Buy) | |
| POINT Biopharma Global Inc | Gerald L. Hogue | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jun 2023 | 44,749 | 44,749 | - | - | Stock Option (Right to Buy) | |
| POINT Biopharma Global Inc | Gerald L. Hogue | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 6.97 per share. | 21 Mar 2023 | 17,936 | 21,596 | - | 7.0 | 125,014 | Common Stock |
| POINT Biopharma Global Inc | Gerald L. Hogue | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 21 Mar 2023 | 17,936 | 17,936 | - | - | Stock Option (Right to Buy) | |
| POINT Biopharma Global Inc | Gerald L. Hogue | Director | Purchase of securities on an exchange or from another person at price $ 6.82 per share. | 25 Nov 2022 | 3,660 | 3,660 | - | 6.8 | 24,943 | Common Stock |
| POINT Biopharma Global Inc | Gerald L. Hogue | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jun 2022 | 25,614 | 25,614 | - | - | Stock Option (Right to Buy) | |
| POINT Biopharma Global Inc | Gerald L. Hogue | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jul 2021 | 25,000 | 25,000 | - | - | Stock Option (Right to Buy) |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges